mHealth for the early diagnosis and effective treatment of cutaneous leishmaniasis
- Conditions
- Cutaneous leishmaniasis (CL)Infections and InfestationsCutaneous leishmaniasis
- Registration Number
- ISRCTN54865992
- Lead Sponsor
- Centro Internacional de Entrenamiento e Investigaciones Medicas
- Brief Summary
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36972285/ results (added 28/03/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 104
1. Residence in one of the three veredas (townships) previously identified as:
1.1. Having a relatively high incidence of CL in the Colombia National System of Public Health Surveillance (SIVIGILA)
1.2. Safe to work
1.3. Relatively accessible
2. At least one cutaneous lesion
1. Mucosal leishmaniasis
2. Contraindication to receive treatment in the area of residence, i.e. with condition which requires treatment in the IPS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of participants seen at ideal study week 26, evidenced by standard medical records in the control arm and data entered into the app by the community health worker in the mHealth arm
- Secondary Outcome Measures
Name Time Method